BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 19536169)

  • 1. miR-34b/miR-34c: a regulator of TCL1 expression in 11q- chronic lymphocytic leukaemia?
    Cardinaud B; Moreilhon C; Marcet B; Robbe-Sermesant K; LeBrigand K; Mari B; Eclache V; Cymbalista F; Raynaud S; Barbry P
    Leukemia; 2009 Nov; 23(11):2174-7. PubMed ID: 19536169
    [No Abstract]   [Full Text] [Related]  

  • 2. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181.
    Pekarsky Y; Santanam U; Cimmino A; Palamarchuk A; Efanov A; Maximov V; Volinia S; Alder H; Liu CG; Rassenti L; Calin GA; Hagan JP; Kipps T; Croce CM
    Cancer Res; 2006 Dec; 66(24):11590-3. PubMed ID: 17178851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TCL1 targeting miR-3676 is codeleted with tumor protein p53 in chronic lymphocytic leukemia.
    Balatti V; Rizzotto L; Miller C; Palamarchuk A; Fadda P; Pandolfo R; Rassenti LZ; Hertlein E; Ruppert AS; Lozanski A; Lozanski G; Kipps TJ; Byrd JC; Croce CM; Pekarsky Y
    Proc Natl Acad Sci U S A; 2015 Feb; 112(7):2169-74. PubMed ID: 25646413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stromal cells modulate TCL1 expression, interacting AP-1 components and TCL1-targeting micro-RNAs in chronic lymphocytic leukemia.
    Sivina M; Hartmann E; Vasyutina E; Boucas JM; Breuer A; Keating MJ; Wierda WG; Rosenwald A; Herling M; Burger JA
    Leukemia; 2012 Aug; 26(8):1812-20. PubMed ID: 22460735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia.
    Calin GA; Pekarsky Y; Croce CM
    Best Pract Res Clin Haematol; 2007 Sep; 20(3):425-37. PubMed ID: 17707831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TCL1 shows a regulated expression pattern in chronic lymphocytic leukemia that correlates with molecular subtypes and proliferative state.
    Herling M; Patel KA; Khalili J; Schlette E; Kobayashi R; Medeiros LJ; Jones D
    Leukemia; 2006 Feb; 20(2):280-5. PubMed ID: 16341048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model.
    Bresin A; Callegari E; D'Abundo L; Cattani C; Bassi C; Zagatti B; Narducci MG; Caprini E; Pekarsky Y; Croce CM; Sabbioni S; Russo G; Negrini M
    Oncotarget; 2015 Aug; 6(23):19807-18. PubMed ID: 26090867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IGHV3-21 gene usage is associated with high TCL1 expression in chronic lymphocytic leukemia.
    Mansouri MR; Sevov M; Aleskog A; Jondal M; Merup M; Sundström C; Osorio L; Rosenquist R
    Eur J Haematol; 2010 Feb; 84(2):109-16. PubMed ID: 19889012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA-34b/c on chromosome 11q23 is aberrantly methylated in chronic lymphocytic leukemia.
    Deneberg S; Kanduri M; Ali D; Bengtzen S; Karimi M; Qu Y; Kimby E; Mansouri L; Rosenquist R; Lennartsson A; Lehmann S
    Epigenetics; 2014 Jun; 9(6):910-7. PubMed ID: 24686393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.
    Corney DC; Flesken-Nikitin A; Godwin AK; Wang W; Nikitin AY
    Cancer Res; 2007 Sep; 67(18):8433-8. PubMed ID: 17823410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tcl1 as a model for lymphomagenesis.
    Pekarsky Y; Zanesi N; Aqeilan R; Croce CM
    Hematol Oncol Clin North Am; 2004 Aug; 18(4):863-79, ix. PubMed ID: 15325703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunophenotype-related microRNA expression in canine chronic lymphocytic leukemia.
    Gioia G; Mortarino M; Gelain ME; Albonico F; Ciusani E; Forno I; Marconato L; Martini V; Comazzi S
    Vet Immunol Immunopathol; 2011 Aug; 142(3-4):228-35. PubMed ID: 21663977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tumor suppressor axis p53/miR-34a regulates Axl expression in B-cell chronic lymphocytic leukemia: implications for therapy in p53-defective CLL patients.
    Boysen J; Sinha S; Price-Troska T; Warner SL; Bearss DJ; Viswanatha D; Shanafelt TD; Kay NE; Ghosh AK
    Leukemia; 2014 Feb; 28(2):451-5. PubMed ID: 24217154
    [No Abstract]   [Full Text] [Related]  

  • 14. TCL1A and ATM are co-expressed in chronic lymphocytic leukemia cells without deletion of 11q.
    Garding A; Bhattacharya N; Haebe S; Müller F; Weichenhan D; Idler I; Ickstadt K; Stilgenbauer S; Mertens D
    Haematologica; 2013 Feb; 98(2):269-73. PubMed ID: 22875623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression and significance of microRNAs in the p53 pathway in ovarian cancer cells and serous ovarian cancer tissues].
    Zhang Q; He XJ; Ma LP; Li N; Yang J; Cheng YX; Cui H
    Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):885-90. PubMed ID: 22340095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MIR21 is differentially expressed in the lymphoid tissue and modulated by stromal signalling in chronic lymphocytic leukaemia.
    Danilova OV; Paiva C; Kaur P; Kamal A; Sempere LF; Danilov AV
    Br J Haematol; 2015 Jul; 170(2):272-5. PubMed ID: 25643738
    [No Abstract]   [Full Text] [Related]  

  • 17. Stromal cells and CD40 ligand (CD154) alter the miRNome and induce miRNA clusters including, miR-125b/miR-99a/let-7c and miR-17-92 in chronic lymphocytic leukaemia.
    Willimott S; Wagner SD
    Leukemia; 2012 May; 26(5):1113-6. PubMed ID: 22024720
    [No Abstract]   [Full Text] [Related]  

  • 18. Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status.
    Hüttmann A; Klein-Hitpass L; Thomale J; Deenen R; Carpinteiro A; Nückel H; Ebeling P; Führer A; Edelmann J; Sellmann L; Dührsen U; Dürig J
    Leukemia; 2006 Oct; 20(10):1774-82. PubMed ID: 16932341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of rapamycin on mouse chronic lymphocytic leukemia and the development of nonhematopoietic malignancies in Emu-TCL1 transgenic mice.
    Zanesi N; Aqeilan R; Drusco A; Kaou M; Sevignani C; Costinean S; Bortesi L; La Rocca G; Koldovsky P; Volinia S; Mancini R; Calin G; Scott CP; Pekarsky Y; Croce CM
    Cancer Res; 2006 Jan; 66(2):915-20. PubMed ID: 16424025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR deregulation in CLL.
    Balatti V; Pekarky Y; Rizzotto L; Croce CM
    Adv Exp Med Biol; 2013; 792():309-25. PubMed ID: 24014303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.